Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Market status
Market status
Under Development
Products 21 to 30 of 119
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Biodata Tools/Medicine
by
Girihlet
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Research
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/28 16:57 (7 years ago)
Known funding amount:
250,000 USD
Funding types:
Private Funding
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
BioDirect Technology: RNAi pest control solution
by
Monsanto
Biotech components:
Enzyme
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Plant
Production process:
Open Release
Source:
NASEM Database
Trading symbol:
MON
(NYSE)
Value chain stage:
Finished Product
Biofood Systems Clean Meat
by
Biofood Systems
Biotech components:
Animal
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/07/02 11:19 (6 years ago)
Date last modified:
2019/07/02 11:19 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Under Development
+
More information needed
Organization type(s):
Private Company
Product categories:
Food
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
BioIsoprene
by
DuPont
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Biological Fungicide - Willaertia magna
by
Amoéba
Biotech components:
Bacteria
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:35 (5 years ago)
Date last modified:
2020/12/18 14:35 (5 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Food & Agriculture
Market status:
Under Development
+
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Other
Production process:
Open Release
Source:
Web search
Trading symbol:
ALMIB
(EPA)
Value chain stage:
Finished Product
Biological Light Sources
by
Glowee
Biotech components:
Bacteria
Business models:
B2C
Country of production:
France
Country of distribution:
France
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/09/19 11:53 (7 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Finished Product
BSG005 for Systemic Fungal Infections
by
Biosergen ES
Biotech components:
Bacteria
Business models:
B2B
Country of production:
Norway
Country of distribution:
N/A
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
Venture Capital
Industry:
Health
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Butamax Bio-Isobutanol
by
Butamax
Biotech components:
Plant
Business models:
B2C
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/10/02 15:45 (7 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
C3007
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Open Release
Source:
Web search
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
C3010
by
Yield10 Bioscience
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (7 years ago)
Date last modified:
2018/08/30 11:49 (7 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Public Company
Product categories:
Additive
Production process:
Open Release
Source:
Web search
Trading symbol:
YTEN
(NASDAQ)
Value chain stage:
Input
1
2
3
4
5
6
7
8
9
10
…
12
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
